Pharmaceutical companies are learning quite fast, and some of them have very strong management and track records, irrespective of what the USFDA's observations, Lalit Nambiar, EVP- Fund Manager & Head of Research, UTI Mutual Funds.
first published: Apr 21, 2016 12:31 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty registers third straight week of gains, up 2% in November | Closing Bell
Live: Can Nifty continue to step up its move to fresh peaks? | Opening Bell
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
Live: Will bulls take Nifty to fresh lifetime highs today? | Opening Bell
